Dr Julie Tzu-Wen Wang is currently a Senior Research and Teaching Fellow in Nanomedicine at King’s College London. Julie obtained her BSc degree in Clinical Laboratory Sciences & Medical Biotechnology and MSc in Biomedical Engineering from National Taiwan University in 2002 and 2004. Julie undertook her PhD in Photobiology in Cancer Therapeutics under the supervision of Professor SG Bown & Professor AJ MacRobert at the Division of Surgery and Interventional Science, University College London. The project focused on a specialised cancer treatment utilising Photochemical Internalisation, a light-induced site-specific drug delivery technology, in combination with chemotherapy for cancer treatments. PCI Biotech, a Norwegian Pharmaceutic company, had in part supported her PhD studies and later funded her first post-doctoral fellowship, conducting a translational project in parallel to the Phase I clinical trial undertaken at UCL Hospital. Julie’s research focus moved to the field of nanomedicine and drug delivery after joining UCL School of Pharmacy (PIs: Professor K Kostarelos & Professor KT Al-Jamal) and then KCL Institute of Pharmaceutical Science (PI: Prof KT Al-Jamal) in 2011 and 2012. Since then, her research focus has been on the pre-clinical translation of nanomedicines for image-guided delivery of drug/gene/radionuclide mostly for cancer and brain diseases, with work funded by EPSRC, BBSRC, Worldwide Cancer Research, EU FP7-ITN programme, Brain Tumour Charity and British Council.